← All trials
NCT02338687
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2014
- Primary completion
- Jul 31, 2016
- Completion date
- Oct 31, 2016
- First posted
- Jan 14, 2015
- Last posted
- Feb 4, 2016
- Enrollment
- 1040
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Federal University of Sao PauloLead sponsor
- Federal University of Sao PauloReponsible party - principal investigator
- Federal University of Sao PauloStudy chair
- Federal University of AmazonasCollaborator
- Federal University of Sao PauloSponsor investigator
- Federal University of Sao PauloOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.